Cargando…
PB2005: AZACITIDINE IN COMBINATION WITH 14-DAY VENETOCLAX VERSUS AZACITIDINE MONOTHERAPY FOR MYELODYSPLASTIC SYNDROME WITH INCREASED BLASTS-2 IN CLINICAL PRACTICE SETTING
| Autores principales: | , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10429938/ http://dx.doi.org/10.1097/01.HS9.0000974836.00135.ea |
| _version_ | 1785090835875889152 |
|---|---|
| author | Žučenka, Andrius Čepulytė, Rūta Davainienė, Birutė Vasilevska, Dominika Pileckyte, Regina Trociukas, Igoris Pečeliūnas, Valdas Griškevičius, Laimonas |
| author_facet | Žučenka, Andrius Čepulytė, Rūta Davainienė, Birutė Vasilevska, Dominika Pileckyte, Regina Trociukas, Igoris Pečeliūnas, Valdas Griškevičius, Laimonas |
| author_sort | Žučenka, Andrius |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10429938 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-104299382023-08-17 PB2005: AZACITIDINE IN COMBINATION WITH 14-DAY VENETOCLAX VERSUS AZACITIDINE MONOTHERAPY FOR MYELODYSPLASTIC SYNDROME WITH INCREASED BLASTS-2 IN CLINICAL PRACTICE SETTING Žučenka, Andrius Čepulytė, Rūta Davainienė, Birutė Vasilevska, Dominika Pileckyte, Regina Trociukas, Igoris Pečeliūnas, Valdas Griškevičius, Laimonas Hemasphere Publication Only Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10429938/ http://dx.doi.org/10.1097/01.HS9.0000974836.00135.ea Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
| spellingShingle | Publication Only Žučenka, Andrius Čepulytė, Rūta Davainienė, Birutė Vasilevska, Dominika Pileckyte, Regina Trociukas, Igoris Pečeliūnas, Valdas Griškevičius, Laimonas PB2005: AZACITIDINE IN COMBINATION WITH 14-DAY VENETOCLAX VERSUS AZACITIDINE MONOTHERAPY FOR MYELODYSPLASTIC SYNDROME WITH INCREASED BLASTS-2 IN CLINICAL PRACTICE SETTING |
| title | PB2005: AZACITIDINE IN COMBINATION WITH 14-DAY VENETOCLAX VERSUS AZACITIDINE MONOTHERAPY FOR MYELODYSPLASTIC SYNDROME WITH INCREASED BLASTS-2 IN CLINICAL PRACTICE SETTING |
| title_full | PB2005: AZACITIDINE IN COMBINATION WITH 14-DAY VENETOCLAX VERSUS AZACITIDINE MONOTHERAPY FOR MYELODYSPLASTIC SYNDROME WITH INCREASED BLASTS-2 IN CLINICAL PRACTICE SETTING |
| title_fullStr | PB2005: AZACITIDINE IN COMBINATION WITH 14-DAY VENETOCLAX VERSUS AZACITIDINE MONOTHERAPY FOR MYELODYSPLASTIC SYNDROME WITH INCREASED BLASTS-2 IN CLINICAL PRACTICE SETTING |
| title_full_unstemmed | PB2005: AZACITIDINE IN COMBINATION WITH 14-DAY VENETOCLAX VERSUS AZACITIDINE MONOTHERAPY FOR MYELODYSPLASTIC SYNDROME WITH INCREASED BLASTS-2 IN CLINICAL PRACTICE SETTING |
| title_short | PB2005: AZACITIDINE IN COMBINATION WITH 14-DAY VENETOCLAX VERSUS AZACITIDINE MONOTHERAPY FOR MYELODYSPLASTIC SYNDROME WITH INCREASED BLASTS-2 IN CLINICAL PRACTICE SETTING |
| title_sort | pb2005: azacitidine in combination with 14-day venetoclax versus azacitidine monotherapy for myelodysplastic syndrome with increased blasts-2 in clinical practice setting |
| topic | Publication Only |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10429938/ http://dx.doi.org/10.1097/01.HS9.0000974836.00135.ea |
| work_keys_str_mv | AT zucenkaandrius pb2005azacitidineincombinationwith14dayvenetoclaxversusazacitidinemonotherapyformyelodysplasticsyndromewithincreasedblasts2inclinicalpracticesetting AT cepulyteruta pb2005azacitidineincombinationwith14dayvenetoclaxversusazacitidinemonotherapyformyelodysplasticsyndromewithincreasedblasts2inclinicalpracticesetting AT davainienebirute pb2005azacitidineincombinationwith14dayvenetoclaxversusazacitidinemonotherapyformyelodysplasticsyndromewithincreasedblasts2inclinicalpracticesetting AT vasilevskadominika pb2005azacitidineincombinationwith14dayvenetoclaxversusazacitidinemonotherapyformyelodysplasticsyndromewithincreasedblasts2inclinicalpracticesetting AT pileckyteregina pb2005azacitidineincombinationwith14dayvenetoclaxversusazacitidinemonotherapyformyelodysplasticsyndromewithincreasedblasts2inclinicalpracticesetting AT trociukasigoris pb2005azacitidineincombinationwith14dayvenetoclaxversusazacitidinemonotherapyformyelodysplasticsyndromewithincreasedblasts2inclinicalpracticesetting AT peceliunasvaldas pb2005azacitidineincombinationwith14dayvenetoclaxversusazacitidinemonotherapyformyelodysplasticsyndromewithincreasedblasts2inclinicalpracticesetting AT griskeviciuslaimonas pb2005azacitidineincombinationwith14dayvenetoclaxversusazacitidinemonotherapyformyelodysplasticsyndromewithincreasedblasts2inclinicalpracticesetting |